Aimin Zhang
Tianjin, 300100, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Dioscin suppresses colitis-associated colorectal tumorigenesis by inhibiting PPARγ-mediated fatty acid oxidation in TAMs.
Journal: International immunopharmacology
Published: January 18, 2026
Serum-Amyloid-A to High-Density-Lipoprotein-Cholesterol Ratio: superior biomarker for early diagnosis of coronary artery disease with clinically relevant stenoses and development of machine learning diagnostic model.
Journal: Frontiers in cardiovascular medicine
Published: October 08, 2025
The KDM6B/SLC10A2 Axis Suppresses MDSCs Recruitment via ERK/AP-1 Signaling in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 29, 2025
FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening.
Journal: Clinical epigenetics
Published: March 29, 2025
FATS alleviates ulcerative colitis by inhibiting M1 macrophage polarization and aerobic glycolysis through promoting the ubiquitination-mediated degradation of HIF-1α.
Journal: Biochemical pharmacology
Published: February 07, 2025
CDH3 Is an Effective Serum Biomarker of Colorectal Cancer Distant Metastasis Patients.
Journal: Journal of Cancer
Published: May 11, 2024
Hydroxygenkwanin suppresses peritoneal metastasis in colorectal cancer by modulating tumor-associated macrophages polarization.
Journal: Chemico-biological interactions
Published: March 14, 2024
Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer.
Journal: Cancer cell international
Published: September 03, 2023
Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer.
Journal: International immunopharmacology
Published: December 06, 2022
Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
Journal: Clinical epigenetics
Published: July 15, 2021
Last Updated: 09/26/2026